经皮冠状动脉介入治疗术后急性支架内血栓形成原因及治疗策略解析1例
被引量:1
摘要
急性支架内血栓形成是经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)的严重并发症之一,虽然发生率并不高,但是具有发病急,预后不良等特点。本文将报道1例典型的急性支架内血栓病例,并对其形成原因及治疗策略进行解析。
出处
《中国介入心脏病学杂志》
2015年第11期658-660,共3页
Chinese Journal of Interventional Cardiology
参考文献6
-
1D'Ascenzo F, Bollati M, Clementi F, et al. Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. Int J Cardiol,2013, 167:575-584.
-
2张燕,任艺虹,周超飞,张庆考,刘国树,刘陪沛.经皮冠状动脉介入治疗术后急性、亚急性支架内血栓形成的危险因素分析[J].中国循环杂志,2013,28(1):17-20. 被引量:33
-
3Hobson AR, Qureshi Z, Banks P. Gender and responses to aspirin and clopidogrel: insights using short thrombelastography. Cardiovasc Therapy,2009,27 : 246-252.
-
4刘然,师树田,索旻,王成钢,原琳,祖晓麟,张新勇,阙斌,艾辉,王春梅,聂绍平.对氯吡格雷低反应患者换用替格瑞洛后的有效性与安全性评价[J].中国介入心脏病学杂志,2014,22(1):12-17. 被引量:52
-
5Steg PG, James S, Harrington RA, et al. Ticagrelor versus elopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis. Circulation, 2010,12 : 2131 - 2141.
-
6Storey RF, Angiolillo D J, Patil SB, et al. Inhibitory effects of tieagrelor compared with elopidogrel on platelet function in patients with acute coronary syndromes : the PLATO ( PLATelet inhibition and patient Outcomes ) PLATELET substudy. J Am Coil Cardio1,2010,56 : 1456-1462.
二级参考文献31
-
1杜润,张瑞岩.晚期支架贴壁不良研究进展[J].国际心血管病杂志,2008,35(6):353-356. 被引量:4
-
2中国成人血脂异常防治指南制定联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志,2007,:35-413,390.
-
3de la Torre-Hernandez JM, Alfonso F, Hernandez F, et al. Drug-eluting stent thrombosis:results from the multicenter Spanish registry ESTRO- FA. J Am Coil Cardiol,2008 ,51:986-990.
-
4Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coro- nary stent trials: a case for standardized definations. Circiulation, 2007,115:2344-2351.
-
5Palmerini T, Dangas G, Mehran R, et al. Predictors and implications of stent thrombosis in non-ST-segment elevation acute coronary syn- dromes : the ACUITY TriM. Circ Cardiovasc Interv ,2011,4:577-584.
-
6Kimura T, Morimoto T, Kozuma K, et al. Comparisons of baseline de- mographics, clinical presentation, and long-term outcome among pa- tients with early,late, and very late stent thrombosis of sirolimus-elu- ring stents : Observations from the Registry of Stent Thrombosis for Re- view and Reevaluation(RESTART). Circulation ,2010,122:52-61.
-
7Dangas GD, Caixeta A, Mehran R, et al. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myo- cardial infarction. Circulation ,2011,123 : 1745-1756.
-
8Heestermans AA, van Werkum JW, Zwart B, et al. Acute and subacute stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction : incidence, predictors and clinical outcome, j Thromb Haemost ,2010,8:2385-2393.
-
9Kuchulakanti PK,Chu WW, Torguson R, et al. Correlates and long- term outcomes of angiographically proven stent thrombosis with siroli- mus-and paclitaxel-eluting stents. Circulation, 2006, 113 : 1108- 1113.
-
10D' Ascenzo F, Bollati M, Clementi F, et al. Incidence and predictors of coronary stent thrombosis : Evidence from an international collabo- rative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. Int J Cardiol,2012. [ Epub ahead of print].
共引文献83
-
1郑来金.PCI术后住院期间支架内急性亚急性血栓形成的防治措施[J].世界最新医学信息文摘,2021(13):184-185.
-
2马良鹏,唐静宜,蒋捷,胡磊,张耕.利用CYP2C19基因分型指导经皮冠状动脉介入术后个体化抗血小板治疗1例[J].今日健康,2016,15(7):111-111.
-
3崔惠康,张叶.急诊介入和静脉溶栓治疗对急性心肌梗死患者心率变异性影响[J].安徽医药,2013,17(8):1400-1401. 被引量:21
-
4刘小宁,杨跃进,吴永健,颜红兵,陈珏,袁晋青,钱杰,邱洪,杨伟宪,俞梦越,慕朝伟,高展,唐熠达,王天杰,徐波,许亮,孙中伟,谢丽华,宁宇.光学相干断层成像方法评价冠状动脉介入治疗术后即刻药物洗脱支架贴壁情况[J].中国循环杂志,2013,28(5):356-359. 被引量:4
-
5芮浩淼.氯吡格雷在预防冠心病介入治疗心血管不良事件发生中的疗效[J].中国实用医刊,2014,41(1):111-112. 被引量:13
-
6裴玮娜,谢瑞芹,崔炜,刘凡,姜云发,肖冰,闫智慧.曲美他嗪与尼可地尔对经皮冠状动脉介入治疗相关心肌损伤干预作用的比较[J].中国循环杂志,2014,29(4):256-260. 被引量:69
-
7刘俊,朱艳虹,汪琳,栾家杰.临床药师参与1例经皮冠状动脉介入术后支架内血栓形成的个体化抗血小板治疗[J].中国医院药学杂志,2014,34(10):852-855. 被引量:4
-
8李学香.替罗非班联合血栓抽吸导管预处理对ST段抬高型心肌梗死患者即刻或择期经皮冠状动脉介入治疗的影响[J].广州医学院学报,2013,41(6):37-40. 被引量:4
-
9黄建波,周建华,徐树东,热娜.非梗死相关血管择期PCI术后反复支架内亚急性血栓形成一例[J].海南医学,2019,30(1):127-128. 被引量:2
-
10马威,黄琨,孙淑娴,张宇,贾风顺,郑川燕,王兆祥,李昌义,亢小丽,吴峥,纪征.替格瑞洛与氯吡格雷在非氯吡格雷抵抗PCI患者术后的应用效果[J].中国老年学杂志,2019,39(1):1-5. 被引量:18
同被引文献10
-
1Nakano M,Yahagi K. Otsuka F. et al. Causes of early stent thrombosis in patients pI~senting with acute coronary syndrome: an ex vivo human autopsy study. J Am Coil Cardiol, 2014, 63 ( 23 ) : 2510-2520.
-
2Schwartz BG, Khmer RA. Corona~' no reflow. J Mol Cell Cardiol, 2012, 52(4):873-882.
-
3Ehnariah S, Jang IK. Acute stent ti~rombosis: technical complication or inadequate antithronfi~otie tt~erapy? An uptieal coherence tomography study. JACC Cardiovasc Interv, 2012, 5 (2) : e3-e4.
-
4Dangas GD,Claessen BE, Mehran R, et al. Development and validation of a stent thrombosis risk score in patients with acute cnnmary syndromes. JACC Cardiovasc Inter',', 2012, 5 ( I 1 ) : 1097-1105.
-
5Witzenbichler B. Maehara A, Weisz (,, el al. TCT-21 use of IVUS reduces stent thrombosis: results from the pn~spective, multicenter ADAPT-DES study. J Am Coil Cardiol, 2012, 60: B6-B7.
-
6Parodi G, La Manna A, Di Vito L. et al. Stent-related defects in patients presenting with stent thrombosis: differences at optical coherence tomngraphy between subacute and late/very late thrombosis in the Mechanism Of Stent Thrombosis ( MOST ) study. Eun~lntervention, 2013. 9 (8) :936-944.
-
7Gilard M,Barragan P, Not'yani AA, et al. 6- vel'sus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial. J Am Coil Caniiol, 2015, 65(8) :777-786.
-
8Valenti R, Marcucci R, Comito V, et al. Prasugrel in clopido~cl nunresponders undergoing percutaneous eoronary intervention : the RECLOSE-3 study (Responsiveness to Clnpidogrel and Stent Thrombosis). JACC Cantiovasc luterv, 2015, 8 (12):1563- 1570.
-
9Faber JE, Chilian WM, Deindl E, et al. A brief etymology of the collateral circulation. Arterioscler Thromb Vasc Biol, 2014, 34 (9) : I854-1859.
-
10黄建波,袁战军,周建华,单文军,热娜.急性心肌梗塞急诊冠脉内支架植入后支架血栓形成的原因及处理[J].心血管康复医学杂志,2010,19(3):299-301. 被引量:12
-
1郑欲知,李振华.机械通气中肺保护性通气策略解析[J].医疗装备,2005,18(3):4-6. 被引量:2
-
2窦晓光,李智伟.慢性乙型肝炎治疗目标及策略解析[J].医学与哲学,2005,26(09X):49-50. 被引量:2
-
3潘锦汉,钟世勤,陈端,钟惠娟,张立建.血小板功能检测指导急性冠脉综合征抗血小板治疗的研究[J].临床医学工程,2014,21(11):1415-1416. 被引量:1
-
4罗裕,Anutebeh Verdo Zisuh,张代富.血小板功能检测在冠心病患者中的应用[J].心血管病学进展,2011,32(4):512-516. 被引量:4
-
5苗青,吴伟利,张志联,薛玲,李亮,郝国贞.氯吡格雷低反应的AMI患者围术期加量应用氯吡格雷的疗效及安全性[J].中国老年学杂志,2010,30(4):530-531. 被引量:3
-
6翟光耀,周玉杰.冠心病合并糖尿病患者经皮冠状动脉介入治疗后氯吡格雷低反应的发生率及危险因素[J].中国医药导报,2016,13(3):13-16. 被引量:14
-
7牛怀明.急性支架内血栓形成伴氯吡格雷低反应一例[J].中国介入心脏病学杂志,2015,23(1):40-41.
-
8陈韬,朱荔,赵仙先,李攀,马丽萍.氯吡格雷抵抗的实验室诊断及临床价值[J].国际心血管病杂志,2015,42(4):225-228. 被引量:8
-
9史晓红,吴迪.血栓弹力图指导下的冠心病个体化抗血小板治疗[J].中国心血管病研究,2015,13(11):966-970. 被引量:4
-
10姜绮霞,梁春.从抗血小板治疗的剩余风险看临床血小板功能检测和新药研发[J].上海医学,2013,36(9):742-745. 被引量:1